Toggle navigation
About Us
Science & Innovation
Products and Resources
Our Responsibility
Careers
Investors
Media
Toggle navigation
Press Releases
Featured News
Press Statements
Subscribe
Media Contacts
Social Media
Press Releases
Year
All Years
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Category
All Categories
Corporate News
Product News
Vaccines News
Uncategorized
Keywords
Go
Advanced Search
Search
Search Headlines Only
Category
All Categories
Corporate News
Product News
Vaccines News
Uncategorized
From
To
Asset Types
Video
Audio
Photos
Documents
Events
Standard
Nov 6, 2019
New data to be presented at ASH 2019 highlight Sanofi's commitment to treat challenging blood cancers and rare blood disorders
*Oncology: New data from investigational isatuximab pivotal study for the treatment of relapsed/refractory multiple myeloma
Nov 6, 2019
New data for isatuximab in multiple myeloma to be presented at ASH 2019
Nov 4, 2019
FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older
* Will be available in fall 2020, in time for the 2020-2021 flu season
Nov 4, 2019
Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes
Oct 31, 2019
Sanofi Q3 well on track
Video
1
Photos
4
Show
5
10
25
50
100
per page
«
1
…
9
10
11
12
13
14
15
…
168
»
Print
Email page
RSS